Severe acute respiratory syndrome coronavirus 2 infection, angiotensin-converting enzyme 2 and treatment with angiotensin-converting enzyme inhibitors or angiotensin II type 1 receptor blockers
Riccardo Sarzani, Federico Giulietti, Chiara Di Pentima, Piero C. Giordano, Francesco Spannella
Topics & Concepts
MedicineAngiotensin-converting enzymeAngiotensin Receptor BlockersAngiotensin-converting enzyme 2EnzymeRenin–angiotensin systemAngiotensin IIReceptorCoronavirusPharmacologyCoronavirus disease 2019 (COVID-19)Internal medicineDiseaseBiochemistryBlood pressureInfectious disease (medical specialty)ChemistryCOVID-19 Clinical Research StudiesSARS-CoV-2 and COVID-19 ResearchVitamin C and Antioxidants Research